sanofi-aventis Canada Inc.
Registration:
29
of
41
(2016-04-05
to
2016-10-03)
Legislative Proposal, Bill or Resolution
- Patent Act as it relates to the regulation of intellectual property for therapeutic products
Legislative Proposal, Bill or Resolution, Policies or Program
- Comprehensive Economic and Trade Agreement Negotiations as it relates to the protection of intellectual property rights.
Legislative Proposal, Bill or Resolution, Regulation
- Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products
Policies or Program
- Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
- Policy or program: National pharmacare with respect to the coordinaton of drug plan policies and programs
- Research and Development Legislative Proposal, Policy or Program, with respect to the strategy on innovation.
- Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Policies or Program, Regulation
- Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees
- Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
Regulation
- Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.